Creative Planning

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1540235 OVERLAND PARK, KS

Position in CRNX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,514,611

-$433,484 QoQ

Shares Held

40,476

-24.5% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#108

of 266 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

Creative Planning holds $452,608,635 across 219 Biotechnology names. CRNX ranks #62 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	127,672	$63,418,511
2	REGN	Regeneron Pharmaceuticals, Inc.	36,949	$23,039,178
3	EXEL	Exelixis, Inc.	270,292	$14,706,586
4	INCY	Incyte Corp	110,664	$12,544,870
5	CYTK	Cytokinetics Inc	141,939	$12,091,783
6	RVMD	Revolution Medicines, Inc.	64,120	$12,008,393
7	ARGX	Argenx SE	12,744	$11,823,500
8	BMRN	Biomarin Pharmaceutical Inc	153,161	$8,763,872

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,514,611	40,476	-24.5%	Shares	Defined	2026-08-13
2026-03-31	$1,948,095	53,637	+13.3%	Shares	Sole	2026-05-12
2025-12-31	$2,202,792	47,321	+16.6%	Shares	Sole	2026-02-17
2025-09-30	$1,689,823	40,572	+42.5%	Shares	Defined	2025-11-14
2025-06-30	$818,768	28,469	-4.8%	Shares	Sole	2025-08-08
2025-03-31	$1,003,315	29,914	+11.5%	Shares	Sole	2025-05-15
2024-12-31	$1,372,124	26,836	+35.5%	Shares	Defined	2025-02-14
2024-09-30	$1,012,188	19,808	+52.4%	Shares	Defined	2024-10-11
2024-06-30	$582,133	12,997	+20.6%	Shares	Sole	2024-08-15
2024-03-31	$504,283	10,773	—	Shares	Defined	2024-05-13
No filing history on record for this holder in this stock.